An Updated Pooled Analysis of Glutathione S-transferase Genotype Polymorphisms and Risk of Adult Gliomas |
Yao, Lei
(Department of Neurosurgery, The First Affiliated Hospital)
Ji, Guixiang (School of Public Health, Nanjing Medical University) Gu, Aihua (School of Public Health, Nanjing Medical University) Zhao, Peng (Department of Neurosurgery, The First Affiliated Hospital) Liu, Ning (Department of Neurosurgery, The First Affiliated Hospital) |
1 | Vogl FD, Taioli E, Maugard C, et al (2004). Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev, 13, 1473-9. |
2 | Wiencke JK, Wrensch MR, Miike R, et al (1997). Populationbased study of glutathione S-transferase mu gene deletion in adult glioma cases and controls. Carcinogenesis, 18, 1431-3. DOI |
3 | Wrensch M, Kelsey KT, Liu M, et al (2004). Glutathione-Stransferase variants and adult glioma. Cancer Epidemiol Biomarkers Prev, 13, 461-7. |
4 | Zhang Z, Fu G, Wang M, et al (2008). P53 codon 72 polymorphism and ovarian cancer risk: a meta-analysis. J Nanjing Med University, 22, 279-85. DOI |
5 | Zhang Z, Qiu L, Wang M, et al (2009). The FAS ligand promoter polymorphism, rs763110 (844C4T), contributes to cancer susceptibility: evidence from 19 case-control studies. Europ J Hum Genetics, 17, 1294-303. DOI |
6 | Zhang Z, Xue H, Gong W, et al (2009). FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies. Carcinogenesis, 30, 487-93. DOI |
7 | Zheng Y, Song HL, Higgins JP, et al (2006). Five glutathione S-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med, 3, e91. DOI |
8 | Zhong S, Wyllie AH, Barnes D, et al (1993). Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis, 14, 1821-4. DOI |
9 | Zimniak P, Nanduri B, Pikula S, et al (1994). Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem, 224, 893-9. DOI |
10 | Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
11 | Nebert DW, Vasiliou V (2004). Analysis of the glutathione S-transferase (GST) gene family. Hum Genomics, 1, 460-4. DOI |
12 | Ntais C, Polycarpou A, Ioannidis JP (2005). Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 14, 176-81. |
13 | Parl FF (2005). Glutathione S-transferase genotypes and cancer risk. Cancer Letters, 221, 123-9 DOI |
14 | Pearson WR, Vorachek WR, Xu SJ, et al (1993). Identification of class-A glutathione transferase genes GSTM1-GSTM5 on human chromo- some 1p13. Am J Hum Genet, 53, 220-33. |
15 | Pinarbasi H, Siligb Y, Gurelik M (2005). Genetic polymorphisms of GSTs and their association with primary brain tumor incidence. Cancer Genetics and Cytogenetics, 156, 144-9. DOI |
16 | Roodi N, Dupont WD, Moore JH, et al (2004). Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk. Cancer Res, 64, 1233-6. DOI |
17 | Schwartzbaum JA, Ahlbom A, Lonn S, et al (2007). An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev, 16, 559-65. DOI |
18 | Sorensen M, Autrup H, Tjonneland A, et al (2004). Glutathione s-transferase T1 null-genotype is associated with an increased risk of lung cancer. Int J Cancer, 110, 219-24. DOI |
19 | Taningher M, Malacarne D, Izzotti A, et al (1999). Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat Res, 436, 227-61. DOI |
20 | Trizna Z, de Andrade M, Kyritsis AP, et al (1998). Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas. Cancer Epidemiol Biomarkers Prev, 7, 553-5. |
21 | Geisler SA, Olshan AF (2001). GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. Am J Epidemiol, 154, 95-105. DOI |
22 | Gu D, Wang M, Wang M, et al (2009). The DNA repair gene APE1 T1349G polymorphism and cancer risk: a metaanalysis of 27 case-control studies. Mutagenesis, 24, 507-12. DOI |
23 | Hand PA, Inskip A, Gilford J, et al (1996). Allelism at the glutathione S-transferase GSTM3 locus: interactions with GSTM1 and GSTT1 as risk factors for astrocytoma. Carcinogenesis, 17, 1919-22. DOI |
24 | Hashibe M, Brennan P, Strange RC, et al (2003). Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol. Biomarkers Prev, 12, 1509-17. |
25 | Hung RJ, Boffetta P, Brennan P, et al (2004). GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer, 110, 598-604. DOI |
26 | Ioannidis JP, Rosenberg PS, Goedert JJ, et al (2002). Commentary: meta-analysis of individual participants' data in genetic epidemiology. Am J Epidemiol, 156, 204-10. DOI |
27 | Kondratieva TV, Imyanitov EN, Togo AV, et al (2000). L-MYC and GSTM1 polymorphisms are associated with unfavourable clinical parameters of gliomas. J Exp Clin Cancer Res, 19, 197-200. |
28 | Lai R, Crevier L, Thabane L (2005). Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 14, 1784-90. DOI |
29 | Lau J, Ioannidis JP, Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6. DOI |
30 | Little J, Sharp L, Masson LF, et al (2006). Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in the Grampian region of Scotland. Int J Cancer, 119, 2155-64. DOI |
31 | da Fonte de Amorim L, Rossini A, Mendonça G, et al (2002). CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women. Cancer Lett, 181,179-86. DOI |
32 | Dahabreh IJ, Giannouli S, Gota V, et al (2010). GSTT1 and GSTM1 polymorphisms and myelodysplastic syndrome risk: a systematic review and meta-analysis. Int J Cancer, 126, 1716-23. |
33 | De Roos AJ, Rothman N, Inskip PD, et al (2003). Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev, 12, 14-22. |
34 | Der Simonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. DOI |
35 | Egan KM, Cai Q, Shu XO, et al (2004). Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai breast cancer study and meta-analysis. Cancer Epidemiol. Biomarkers Prev, 13, 197-204. DOI |
36 | Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. Bmj, 315, 629-34. DOI |
37 | Elexpuru-Camiruaga J, Buxton N, Kandula V, et al (1995). Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-Transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) Loci. Cancer Res, 55, 4237-9. |
38 | Engel LS, Taioli E, Pfeiffer R, et al (2002). Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol, 156, 95-109. DOI |
39 | Ezer R, Alonso M, Pereira E, et al (2002). Identification of glutathione S-transferase (GST) polymorphisms in brain tumors and association with susceptibility to pediatric astrocytomas. J Neuro-Oncol, 59, 123-34. DOI |
40 | Gao LB, Pan XM, Li LJ, et al (2011). Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis. PLoS ONE, 6, e20157. DOI |
41 | Alexandrie AK, Nyberg F, Warholm M, Rannug A (2004). Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population. Cancer Epidemiol Biomarkers Prev, 13, 908-14. |
42 | Bailey LR, Roodi N, Verrier CS, et al (1998). Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res, 58, 65-70. |
43 | Boccia S, La Torre G, Gianfagna F, et al (2006). Glutathione S-transferase T1 status and gastric cancer risk: a metaanalysis of the literature. Mutagenesis, 21, 115-23. DOI |
44 | Cabelguenne A, Loriot MA, Stucker I, et al (2001). Glutathioneassociated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy. Int J Cancer, 93, 725-30. DOI |
45 | Chu HY, Wang ML, Shi D, et al (2011). Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies. PLoS ONE, 6, e18108. DOI |
46 | Cotton SC, Sharp L, Little J, et al (2000). Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol, 151, 7-32. DOI |
47 | Coutinho P, Sandim V, Oliveira JA, et al (2010). Lack of association between glutathione S-transferase polymorphisms and primary glioma in a case-control study in Rio de Janeiro. Genet Mol Res, 9, 539-44. DOI |
48 | Custodio AC, Almeida LO, Pinto GR, et al (2010). GSTP1 Ile105Val polymorphism in astrocytomas and glioblastomas. Genet Mol Res, 9, 2328-34. DOI |